Shanghai Medicilon (SHSE:688202) LT-Debt-to-Total-Asset : 0.02 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanghai Medicilon's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.02.

Shanghai Medicilon's long-term debt to total assets ratio increased from Dec. 2023 (0.00) to Dec. 2024 (0.02). It may suggest that Shanghai Medicilon is progressively becoming more dependent on debt to grow their business.

Shanghai Medicilon LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shanghai Medicilon's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon LT-Debt-to-Total-Asset Chart

Shanghai Medicilon Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.02

0.01

0.02

Shanghai Medicilon Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.01	-	-	0.02

Shanghai Medicilon LT-Debt-to-Total-Asset Calculation

Shanghai Medicilon's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	41.667	/	2823.26
	=	0.01

Shanghai Medicilon's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	41.667	/	2823.26
	=	0.01

Shanghai Medicilon (SHSE:688202) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanghai Medicilon LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Medicilon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299

Website

http://www.medicilon.com.cn

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

Executives

Chen Jin Zhang	Director
Chen Guo Xing	Director
Lin Zhang Qing	Director
Peng Shuang Qing	Core technical personnel
Li Zhi Gang	Core technical personnel
Xu Yong Mei	Core technical personnel
Liu Bin Bin	senior management
Zhang Xiao Dong	senior management
Xue Chao	senior management
Ma Xing Quan	senior management
	Directors, senior managers, core technical personn
Cai Jin Na	Directors, senior managers

Shanghai Medicilon Headlines

No Headlines